82
Views
0
CrossRef citations to date
0
Altmetric
Letter to the Editor

A Case of Immunoglobulin G4-associated Anterior Uveitis and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome

, MD, , MD, PhD ORCID Icon & , MD, PhD
Pages 698-699 | Received 13 Dec 2015, Accepted 29 Feb 2016, Published online: 18 May 2016

REFERENCES

  • Kamisawa T, Zen Y, Pillai S, Stone JH. IgG4-related disease. Lancet. 2015;385:1460–1471.
  • Lee CS, Harocopos GJ, Kraus CL, et al. IgG4-associated orbital and ocular inflammation. J Ophthalmic Inflamm Infect. 2015;5:15.
  • Prayson RA. Immunoglobulin G4-related ophthalmic disease presenting as uveitis. J Clin Neurosci. 2015;22:1848–1849.
  • Vasaitis L. IgG4-related disease: a relatively new concept for clinicians. Eur J Intern Med. 2016;27.1–9.
  • Neki NS, Jamn A, Bajal R, et al. Remitting seronegative symmetrical synovitis with pitting oedema. J Ayub Med Coll Abbottabad. 2014;26:628–629.
  • Chiappetta N, Gruber B. Remitting seronegative symmetrical synovitis with pitting edema associated with acute myeloid leukemia. J Rheumatol. 2005;32:1613–1614.
  • Bruscas Izu C, Puertas JR, Cabrerizo-Garcia JL. RS3PE syndrome as a first manifestation of bladder carcinoma. Reumatol Clin. 2013;9:74.
  • Gisserot O, Cremades S, Landais C, et al. RS3PE revealing recurrent non-Hodgkin’s lymphoma. Joint Bone Spine. 2004;71:424–426.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.